Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-19

Clinical Trial Update: Enhancing Muscle Function After Exacerbations of COPD to Limit Its Impact on Physical Activity Decline [NA]

View source ↗

Summary

The completed trial NCT05233137 investigates enhancing muscle function after COPD exacerbations to limit subsequent declines in physical activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: KU Leuven | Conditions: COPD Exacerbation | NA | Status: COMPLETED